Cohero Health, an NYC-based digital health company, has received 510(k) clearance from the FDA for its mobile spirometer, according to a company news announcement.
The handheld, wireless spirometer measures critical lung function metrics with the same precision as clinical-grade spirometers. The mobile spirometer pairs with a smartphone or tablet, enabling real-time measurement and reporting. The device integrates with Cohero Health’s mobile asthma and COPD disease management platform that includes bluetooth sensors that attach to maintenance and rescue medication and mobile apps that track medication usage, and more.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management